Navigation Links
ISIS Reports Phase 1 Data Demonstrating ISIS-TTRRx Produces Significant Reductions in TTR Protein
Date:1/5/2012

life is substantially compromised.  Although, liver transplant replaces mutant TTR, amyloid formation continues due to accumulation of normal TTR protein," said Richard Geary, Ph.D., Senior Vice President of Development at Isis.  "ISIS-TTRRx blocks the production of both normal and mutant TTR, thereby preventing further amyloid accumulation, which may prevent, and potentially reverse, disease progression."

The Phase 1 study of ISIS-TTRRx was a blinded, randomized, placebo-controlled, dose-escalation study designed to assess the safety and pharmacokinetic profile of ISIS-TTRRx in healthy volunteers.  ISIS-TTRRx was evaluated in single and multiple doses ranging from 50 mg per week up to 400 mg per week.  After only four weeks of dosing, subjects in the 200 mg and 400 mg multiple-dose cohorts displayed a mean reduction of 44 percent and 81 percent in TTR levels, respectively.  ISIS-TTRRx was generally well tolerated in all subjects. 

"In this study, we observed substantial dose-dependent reductions in TTR protein of greater than 80 percent.  Based on the mechanism of action and the early data we have presented, we believe that ISIS-TTRRx could provide benefit to patients with FAP," said Brett Monia, Ph.D., Senior Vice President, Drug Discovery and Corporate Development of Isis.  "Together with our partner GSK, we are finalizing the development plan for ISIS-TTRRx, which is intended to achieve an efficient route to registration.  Our next clinical study for ISIS-TTRRx will begin in 2012 and evaluate the effects of the drug on disease progression and other measures of disease burden/improvements on quality of life in patients with FAP."

ABOUT ISIS-TTRRx
Transthyretin amyloidosis is a genetic disease in which the patient inherits a mutant gene that produces a misfolded form of TTR, which progressively accumulates in tissues, impairing their function.  In patients with transthyretin amyloid
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. InterMune Reports Preliminary Fourth Quarter 2011 Esbriet® (pirfenidone) Revenue and Other Recent Business Highlights
2. Quark Pharmaceuticals Reports Favorable Interim Results from Phase I Clinical Study of QPI-1007 in Patients with Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
3. Cardium Reports on Renewed Compliance With NYSE Amex Exchange Listing Guidelines
4. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
5. Solos Endoscopy, Inc. Reports Significant Sales From Its MammoView® Instrument Line
6. VIVUS Reports Topline Findings From FORTRESS
7. Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results
8. Champions Oncology Reports Fiscal 2012 Second Quarter Financial Results
9. American Pacific Reports Fiscal 2011 Results
10. Avanir Pharmaceuticals Reports Fiscal 2011 Fourth Quarter and Year End Financial Results
11. Cantel Medical Reports 25% Increase in Net Income - EPS of $0.35 vs. $0.29 - for Quarter Ended October 31, 2011 on 30% Sales Increase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Dec. 19, 2014   Hospira, Inc. (NYSE: ... injectable drugs and infusion technologies, today announced that the ... Healthcare Conference on Wednesday, Jan. 14, 2015, in ... to begin at 10:30 a.m. Pacific time on Wednesday, ... interested parties through a live audiocast accessible via the ...
(Date:12/19/2014)...  Monarch America Inc. (OTCQB: CANK) ("Monarch America" or ... provide this review of the Company,s recent achievements and ... "Over this past year, we achieved many of our ... to say that Monarch America is in a stronger ... been," stated Eric Hagen , CEO of Monarch ...
(Date:12/19/2014)... YORK , Dec. 18, 2014 Somewhere ... addressing hearing health was forgotten. But Audicus , ... to hear better this new year. Hearing ... facing the aging population, though it is often unaddressed. ... in four has a hearing aid, mainly due to ...
Breaking Medicine Technology:Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3Audicus Will Help People Resolve to Hear Better in 2015 2
... 8 Varian Medical Systems (NYSE: VAR ) ... of fiscal year 2010 following the close of regular trading ... followed by a teleconference available to all interested parties at ... the conference call webcast will be available on the company ...
... growing number of healthcare providers are choosing the ... control over non-file, off-contract spending, focusing on high-cost ... healthcare decision-makers receive sound content, accurate contract price ... rather than after the fact. With greater contract ...
Cached Medicine Technology:Varian Medical Systems Schedules Fourth Quarter FY2010 News Release and Conference Call 2Healthcare Providers Gain Control of Demand Channels With GHX Procurement Suite; 12 Percent Supply Spend Savings Achievable 2Healthcare Providers Gain Control of Demand Channels With GHX Procurement Suite; 12 Percent Supply Spend Savings Achievable 3
(Date:12/20/2014)... Recently, AngelWeddingDress.com has introduced its special offer ... coming Christmas. In the promotion, all buyers worldwide can ... have something special for the women who are looking ... our new collections of 2015 dresses have been unveiled ... greatly discounted prices. Visit our website now before they ...
(Date:12/20/2014)... December 20, 2014 The Twin Cities ... education event in the nation! Over 250 financial professionals ... minute information on the industry, get motivated to protect ... real people facing and overcoming the challenges of disability. ... across the nation came together to attend The 13th ...
(Date:12/19/2014)... Balfleet.com , a leading dress company of wedding ... All the old and new customers can get a ... well-known for its high quality trendy women’s dresses, like ... more. Its formal dresses are quality made and come ... an elegant look when paired with any accessory. ...
(Date:12/19/2014)... 2014 Sub Zero Ice Cream is partnering ... drive Sunday the 28th from 2pm-6pm at the Expo Center ... in Sarasota, FL. , Inquiries regarding time slots and signing ... in the donating process, Sub Zero Ice Cream & Yogurt ... ice cream. , About Sub Zero Ice Cream & Yogurt ...
(Date:12/19/2014)... Missouri (PRWEB) December 19, 2014 Silver ... new official world record -- for the first time ever, ... prestigious record book, Guinness World Records 2015, listing the park’s ... Wooden Roller Coaster. In additional awards announced this week, Silver ... See Christmas Lights in the US,” USA Today’s 10Best awards ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Introduced Its Special Offer For The Coming Christmas 2Health News:The 13th Annual Twin Cities DI Day Now On Video 2Health News:The 13th Annual Twin Cities DI Day Now On Video 3Health News:Balfleet.com Announces Its Formal Dress Promotion For 2015 2Health News:Shark Tank’s Sub Zero Ice Cream Sponsors Blood Drive 2Health News:Silver Dollar City Nets New Titles: Guinness Book of World Records, Plus CNN Travel, USA Today & Fodor’s Top Places for Christmas Lights 2
... 2011 -- Over 10 million people age 12 or older ... drugs in the prior year, according to a 2009 National ... most commonly detected non-alcohol drug in drivers, its role in ... between marijuana use by drivers and risk of a car ...
... -- New research suggests certain long-term psychotherapies may do ... stress disorder (PTSD) following a traumatic event. The ... PTSD didn,t seem to boost a person,s risk of ... when early clinical interventions cannot be provided," as might ...
... sinusitis is presented in a new thesis from Lund University. The ... the costs of the disease to society. Sinusitis is ... a chronic form. In Europe, over nine per cent of the ... thesis is Pernilla Sahlstrand Johnson, a PhD student and ear, nose ...
... , THURSDAY, Oct. 6 (HealthDay News) -- Technology that ... patients who were severely sickened by the H1N1 flu virus, ... their study had limitations, and they noted that debate continues ... At issue is a treatment called extracorporeal membrane oxygenation, which ...
... 6 (HealthDay News) -- People whose parents had a drinking ... they,re under stress, a new study says. Swedish researchers ... they had a family history of alcohol abuse. Both groups ... timed conditions in public) and then allowed to drink. ...
... HealthDay Reporter , THURSDAY, Oct. 6 (HealthDay ... children treated in emergency rooms for traumatic brain injuries, ... report from the U.S. Centers for Disease Control and ... saw 248,418 children with traumatic brain injuries compared to ...
Cached Medicine News:Health News:Marijuana use may double the risk of accidents for drivers 2Health News:Researchers Assess What Works Best to Prevent PTSD 2Health News:New method to diagnose sinusitis could reduce use of antibiotics 2Health News:Oxygenating Blood of Hospitalized H1N1 Flu Patients Saved Lives: Study 2Health News:More Kids Treated for Concussions in ERs: CDC 2Health News:More Kids Treated for Concussions in ERs: CDC 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: